The correlation between tuberculosis and diabetes incidence and the impact of mass migration on the development of tuberculosis and drug-resistant tuberculosis on the example of India and England
Introduction: Tuberculosis is still a major health concern around the world, especially in developing countries with very large populations. Diabetes may be responsible for the progression of Mycobacterium tuberculosis infection. According to the research of some authors, the development of an activ...
| Published in: | Journal of Education, Health and Sport |
|---|---|
| Main Authors: | Dorota Sokół, Arkadiusz Standyło, Jakub Czarnota, Tomasz Skubel, Michał Dobrzyński, Halina Piecewicz-Szczęsna |
| Format: | Article |
| Language: | English |
| Published: |
Kazimierz Wielki University
2019-09-01
|
| Subjects: | |
| Online Access: | https://apcz.umk.pl/JEHS/article/view/27335 |
Similar Items
The correllation between incidence rate of pertussis and vaccination rate of children from 1998 to 2016 in Poland
by: Jakub Czarnota, et al.
Published: (2019-06-01)
by: Jakub Czarnota, et al.
Published: (2019-06-01)
Zinc lozenges efficacy in cold treatment
by: Michał Dobrzyński, et al.
Published: (2019-09-01)
by: Michał Dobrzyński, et al.
Published: (2019-09-01)
MDR Tuberculosis Treatment
by: Juan Espinosa-Pereiro, et al.
Published: (2022-01-01)
by: Juan Espinosa-Pereiro, et al.
Published: (2022-01-01)
Factors associated with multidrug-resistant tuberculosis
by: Md Nurul Amin, et al.
Published: (2009-01-01)
by: Md Nurul Amin, et al.
Published: (2009-01-01)
Resistance of anti-tuberculosis drugs among pulmonary tuberculosis patients in Yemen
by: Anwar K. Al-Madhagi, et al.
Published: (2013-07-01)
by: Anwar K. Al-Madhagi, et al.
Published: (2013-07-01)
Deeplex Sequencing of Mycobacterium Tuberculosis Strains Isolated in Kosovo
by: Rrezarta Bajrami, et al.
Published: (2024-12-01)
by: Rrezarta Bajrami, et al.
Published: (2024-12-01)
Trends in the incidence of Rifampicin resistant Mycobacterium tuberculosis infection in northeastern Nigeria
by: Muhammad M. Ibrahim, et al.
Published: (2022-09-01)
by: Muhammad M. Ibrahim, et al.
Published: (2022-09-01)
Frequency and Structure of Drug Resistance of M. tuberculosis in Pulmonary and Extrapulmonary Tuberculosis
by: P. K. Yablonskiy, et al.
Published: (2024-03-01)
by: P. K. Yablonskiy, et al.
Published: (2024-03-01)
Risk Factors for Multidrug-resistant Tuberculosis
by: Cleopas Martin Rumende
Published: (2018-04-01)
by: Cleopas Martin Rumende
Published: (2018-04-01)
Risk Factors for Multidrug-resistant Tuberculosis
by: Cleopas Martin Rumende
Published: (2018-04-01)
by: Cleopas Martin Rumende
Published: (2018-04-01)
The Role of Risk Factors in the Development of Tuberculosis in Children Exposed to Rifampicin Resistant Tuberculosis
by: N. A. Nikiforenko, et al.
Published: (2021-08-01)
by: N. A. Nikiforenko, et al.
Published: (2021-08-01)
The occurrence of multidrug-resistant Mycobacterium tuberculosis from patients of pulmonary tuberculosis
by: Azhar Iqbal, et al.
Published: (2022-04-01)
by: Azhar Iqbal, et al.
Published: (2022-04-01)
Thoracic Radiography Characteristics of Drug Sensitive Tuberculosis and Multi Drug Resistant Tuberculosis: a Study of Indonesian National Tuberculosis Prevalence Survey
by: Rosalia Sri Sulistijawati, et al.
Published: (2019-04-01)
by: Rosalia Sri Sulistijawati, et al.
Published: (2019-04-01)
Knowledge About Tuberculosis and Multi-Drug Resistant Tuberculosis Among Interns
by: Rupali A Patel, et al.
Published: (2014-03-01)
by: Rupali A Patel, et al.
Published: (2014-03-01)
Multidrug-resistant tuberculosis in Iran: a multicenter study
by: Fatemeh Khelghati, et al.
Published: (2024-01-01)
by: Fatemeh Khelghati, et al.
Published: (2024-01-01)
Evaluation of the multiple doses thiozonide’s pharmacokinetics in patients diagnosed with pulmonary tuberculosis with multidrug-resistant or extensively drug-resistant <i>Mycobacterium tuberculosis</i>
by: А. Yu. Savchenko, et al.
Published: (2024-01-01)
by: А. Yu. Savchenko, et al.
Published: (2024-01-01)
Communicable Episode 20: Tuberculosis today
by: Kathryn Hostettler, et al.
Published: (2025-06-01)
by: Kathryn Hostettler, et al.
Published: (2025-06-01)
Cost-effectiveness of bedaquiline in MDR and XDR tuberculosis in Italy
by: Luigi R. Codecasa, et al.
Published: (2017-01-01)
by: Luigi R. Codecasa, et al.
Published: (2017-01-01)
Health-related quality of life of tuberculosis Patients in Bagdad and Socio-demographic Factors Associated with Multiple Drug Resistant Tuberculosis (MDR TB)
by: Ahmed Abed Marzook
Published: (2019-06-01)
by: Ahmed Abed Marzook
Published: (2019-06-01)
Health-related quality of life of tuberculosis Patients in Bagdad and Socio-demographic Factors Associated with Multiple Drug Resistant Tuberculosis (MDR TB)
by: Ahmed Abed Marzook
Published: (2019-06-01)
by: Ahmed Abed Marzook
Published: (2019-06-01)
Individualised treatment for multidrug‐resistant tuberculosis in New South Wales, Australia
by: Vicky Chang, et al.
Published: (2021-10-01)
by: Vicky Chang, et al.
Published: (2021-10-01)
Potential targets for the new anti-tuberculosis drug of the diarylquinoline group thiozonide
by: А. Yu. Savchenko, et al.
Published: (2025-06-01)
by: А. Yu. Savchenko, et al.
Published: (2025-06-01)
Tuberculosis multirresistente en adolescente: A propósito de un caso
by: Lorena García-Agudelo
Published: (2025-02-01)
by: Lorena García-Agudelo
Published: (2025-02-01)
Multidrug resistant tuberculosis versus non-tuberculous mycobacterial infections: a CT-scan challenge
by: Shahram Kahkouee, et al.
by: Shahram Kahkouee, et al.
Clofazimine for the treatment of tuberculosis
by: Jacob A. M. Stadler, et al.
Published: (2023-02-01)
by: Jacob A. M. Stadler, et al.
Published: (2023-02-01)
Drug-Resistant Tuberculosis, Lebanon, 2016 – 2017
by: Salam El Achkar, et al.
Published: (2019-03-01)
by: Salam El Achkar, et al.
Published: (2019-03-01)
Outcomes of bedaquiline containing regimen in the treatment of adults with drug resistant tuberculosis in a tertiary care centre of Rajasthan
by: Roshni Mary Prince, et al.
Published: (2023-08-01)
by: Roshni Mary Prince, et al.
Published: (2023-08-01)
Drug resistance pattern of M. tuberculosis in category II treatment failure pulmonary tuberculosis patients
by: Fahmida Rahman, et al.
Published: (2013-01-01)
by: Fahmida Rahman, et al.
Published: (2013-01-01)
High Prevalence of Multidrug-Resistant Tuberculosis, Swaziland, 2009–2010
by: Elisabeth Sanchez-Padilla, et al.
Published: (2012-01-01)
by: Elisabeth Sanchez-Padilla, et al.
Published: (2012-01-01)
Issues of Tuberculosis Drug-Resistance in Kharkiv Region and in Ukraine
by: O.S. Shevchenko, et al.
Published: (2019-11-01)
by: O.S. Shevchenko, et al.
Published: (2019-11-01)
Short course chemotherapy in children suffering from drug resistant tuberculosis
by: N. I. Klevno, et al.
Published: (2021-03-01)
by: N. I. Klevno, et al.
Published: (2021-03-01)
Characterization of Mycobacterium tuberculosis genotypes and their correlation to multidrug resistance in Lusaka, Zambia
by: Eddie Samuneti Solo, et al.
Published: (2021-01-01)
by: Eddie Samuneti Solo, et al.
Published: (2021-01-01)
Impact of different tuberculosis history at the onset of future multidrug-resistant tuberculosis: A large, retrospective, population-based cohort study
by: Qinglin Cheng, PhD., et al.
Published: (2021-03-01)
by: Qinglin Cheng, PhD., et al.
Published: (2021-03-01)
Perspectives of targeted chemotherapy with delamanid in the treatment regimens of those with multiple/extensive drug resistant tuberculosis. A success, chance or uncertainty?
by: Aleksey G. Naumov, et al.
Published: (2018-11-01)
by: Aleksey G. Naumov, et al.
Published: (2018-11-01)
The effect of the current chemotherapy of MDR/XDR tuberculosis on QT interval changes in ECG
by: E. M. Zhukova, et al.
Published: (2019-12-01)
by: E. M. Zhukova, et al.
Published: (2019-12-01)
The course of multidrug-resistant pulmonary tuberculosis in HIV-infected people with COVID-19
by: O. M. Raznatovska, et al.
Published: (2022-09-01)
by: O. M. Raznatovska, et al.
Published: (2022-09-01)
Isolation of Mycobacterium tuberculosis and testing their susceptibility to antimicrobial agents by using Bactec 960.
by: Afraa Ali Kadhim, et al.
Published: (2013-06-01)
by: Afraa Ali Kadhim, et al.
Published: (2013-06-01)
The Usefulness of the BD MAX MDR-TB Molecular Test in the Rapid Diagnosis of Multidrug-Resistant Tuberculosis
by: Tomasz Bogiel, et al.
Published: (2025-06-01)
by: Tomasz Bogiel, et al.
Published: (2025-06-01)
Detection of Drug Resistant Mycobacterium Tuberculosis Strains Using Kit SIRE Nitratase®: a Multicenter Study
by: Silvana Spindola de Miranda, et al.
Published: (2020-07-01)
by: Silvana Spindola de Miranda, et al.
Published: (2020-07-01)
Predictive Factors Associated With Multidrug‐Resistant Tuberculosis Among Tuberculosis Patients in Southwest Ethiopia: An Unmatched Case‐Control Study
by: Sileshi Meseret Goshiye, et al.
Published: (2025-11-01)
by: Sileshi Meseret Goshiye, et al.
Published: (2025-11-01)
Similar Items
-
The correllation between incidence rate of pertussis and vaccination rate of children from 1998 to 2016 in Poland
by: Jakub Czarnota, et al.
Published: (2019-06-01) -
Zinc lozenges efficacy in cold treatment
by: Michał Dobrzyński, et al.
Published: (2019-09-01) -
MDR Tuberculosis Treatment
by: Juan Espinosa-Pereiro, et al.
Published: (2022-01-01) -
Factors associated with multidrug-resistant tuberculosis
by: Md Nurul Amin, et al.
Published: (2009-01-01) -
Resistance of anti-tuberculosis drugs among pulmonary tuberculosis patients in Yemen
by: Anwar K. Al-Madhagi, et al.
Published: (2013-07-01)
